(19)
(11) EP 4 522 118 A2

(12)

(88) Date of publication A3:
21.12.2023

(43) Date of publication:
19.03.2025 Bulletin 2025/12

(21) Application number: 23731477.8

(22) Date of filing: 11.05.2023
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 47/26(2006.01)
A61K 38/08(2019.01)
A61K 47/02(2006.01)
A61K 38/00(2006.01)
A61P 27/02(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/0048; A61K 47/26; A61K 47/02; A61K 38/08; A61P 27/02; A61P 29/00
(86) International application number:
PCT/US2023/066879
(87) International publication number:
WO 2023/220676 (16.11.2023 Gazette 2023/46)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 12.05.2022 US 202263341205 P
20.12.2022 US 202263434042 P

(71) Applicant: Okyo Pharma Limited
St Peter Port, Guernsey, GY1 3HB (GG)

(72) Inventor:
  • PATIL, Rajkumar V.
    Keller, Texas 76248 (US)

(74) Representative: Cooley (UK) LLP 
22 Bishopsgate
London EC2N 4BQ
London EC2N 4BQ (GB)

   


(54) CHEMERIN-CONTAINING FORMULATION FOR TREATING DRY EYE DISEASE